Home LiteratureArticle Details
PMID: 2896355 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency.

Conley ME, Lavoie A, Briggs C, Brown P, Guerra C, Puck JM

Abstract

X chromosome-linked severe combined immunodeficiency (XSCID) is characterized by markedly reduced numbers of T cells, the absence of proliferative responses to mitogens, and hypogammaglobulinemia but normal or elevated numbers of B cells. To determine if the failure of the B cells to produce immunoglobulin might be due to expression of the XSCID gene defect in B-lineage cells as well as T cells, we analyzed patterns of X chromosome inactivation in B cells from nine obligate carriers of this disorder. A series of somatic cell hybrids that selectively retained the active X chromosome was produced from Epstein-Barr virus-stimulated B cells from each woman. To distinguish between the two X chromosomes, the hybrids from each woman were analyzed using an X-linked restriction fragment length polymorphism for which the woman in question was heterozygous. In all obligate carriers of XSCID, the B-cell hybrids demonstrated preferential use of a single X chromosome, the nonmutant X, as the active X. To determine if the small number of B-cell hybrids that contained the mutant X were derived from an immature subset of B cells, lymphocytes from three carriers were separated into surface IgM positive and surface IgM negative B cells prior to exposure to Epstein-Barr virus and production of B-cell hybrids. The results demonstrated normal random X chromosome inactivation in B-cell hybrids derived from the less mature surface IgM positive B cells. In contrast, the pattern of X chromosome inactivation in the surface IgM negative B cells, which had undergone further replication and differentiation, was significantly nonrandom in all three experiments [logarithm of odds (lod) score greater than 3.0]. These results suggest that the XSCID gene product has a direct effect on B cells as well as T cells and is required during B-cell maturation.

MeSH Terms
Alleles B-Lymphocytes/analysis Cell Differentiation Dosage Compensation, Genetic Female Genetic Carrier Screening Humans Hybrid Cells/analysis Immunologic Deficiency Syndromes/genetics Male Polymorphism, Restriction Fragment Length
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Conley M E
Department of Pediatrics, Children's Hospital of Philadelphia, PA.
Lavoie A
Briggs C
Brown P
Guerra C
Puck J M
References (39)
39 references, click to expand
  1. Hemizygous expression of glucose-6-phosphate dehydrogenase in erythrocytes of heterozygotes for the Lesch-Nyhan syndrome.
    Proc Natl Acad Sci U S A. 1970 Jan;65(1):214-8 PMID: 5263751
  2. Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation.
    J Clin Invest. 1987 May;79(5):1395-400 PMID: 2883199
  3. Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes.
    J Exp Med. 1973 Dec 1;138(6):1365-78 PMID: 4357682
  4. The origin and development of human tumors studied with cell markers.
    N Engl J Med. 1974 Jul 4;291(1):26-35 PMID: 4598924
  5. Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoic cell lines and in the blood of patients with infectious mononucleosis.
    Clin Immunol Immunopathol. 1975 Mar;3(4):514-24 PMID: 163715
  6. Studies on the thymic dependence of the immunoglobulin classes of the mouse (38570).
    Proc Soc Exp Biol Med. 1975 Feb;148(2):501-4 PMID: 1079085
  7. X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells.
    J Exp Med. 1975 Apr 1;141(4):788-803 PMID: 805203
  8. Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de-novo purine synthesis in lymphocyte transformation.
    Lancet. 1975 Dec 13;2(7946):1179-83 PMID: 53661
  9. Heterogeneity of lymphocyte subpopulations in severe combined immunodeficiency. Evidence against a stem cell defect.
    J Clin Invest. 1976 Jul;58(1):130-6 PMID: 1084354
  10. Severe combined immunodeficiency with B lymphocytes: in vitro correction of defective immunoglobulin production by addition of normal T lymphocytes.
    Clin Exp Immunol. 1976 Oct;26(1):1-10 PMID: 1087209
  11. Selective defect of precursor T cells associated with apparently normal B lymphocytes in severe combined immunodeficiency disease.
    J Pediatr. 1978 Sep;93(3):404-11 PMID: 29085
  12. Surface markers and size of lymphocytes in human umbilical cord blood stimulated into deoxyribonucleic acid synthesis by Epstein-Barr Virus.
    Infect Immun. 1979 Oct;26(1):225-31 PMID: 227794
  13. Heterogeneity of b lymphocyte differentiation in severe combined immunodeficiency disease.
    J Clin Invest. 1980 Sep;66(3):543-50 PMID: 6447166
  14. Development of B lymphocytes in the mouse; studies of the frequency and distribution of surface IgM and IgD in normal and immune-defective CBA/N F1 mice.
    J Immunol. 1980 Oct;125(4):1686-93 PMID: 6997384
  15. Adrenoleukodystrophy: evidence for X linkage, inactivation, and selection favoring the mutant allele in heterozygous cells.
    Proc Natl Acad Sci U S A. 1981 Aug;78(8):5066-70 PMID: 6795626
  16. Lack of mature B cells in nude mice with X-linked immune deficiency.
    J Exp Med. 1982 Mar 1;155(3):903-13 PMID: 6801182
  17. Role of the thymus in directing the development of a subset of B lymphocytes.
    J Exp Med. 1982 Mar 1;155(3):924-36 PMID: 6801183
  18. The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity.
    Adv Immunol. 1982;33:1-71 PMID: 6215838
  19. Patterns of isotype commitment in human B cells: limiting dilution analysis of Epstein Barr virus-infected cells.
    J Immunol. 1983 Apr;130(4):1640-5 PMID: 6300231
  20. Serum IgA1 and IgA2 in normal adults and patients with systemic lupus erythematosus and hepatic disease.
    Clin Immunol Immunopathol. 1983 Mar;26(3):390-7 PMID: 6872349
  21. Deletion and amplification of the HGPRT locus in Chinese hamster cells.
    Mol Cell Biol. 1983 Jun;3(6):1086-96 PMID: 6877239
  22. Epstein-Barr virus transformation of human pre-B cells.
    J Exp Med. 1983 Aug 1;158(2):616-22 PMID: 6310019
  23. Unbalanced X chromosome mosaicism in B cells of mice with X-linked immunodeficiency.
    J Exp Med. 1983 Sep 1;158(3):920-31 PMID: 6604128
  24. Diagnosis and classification of severe combined immunodeficiency disease.
    Birth Defects Orig Artic Ser. 1983;19(3):65-72 PMID: 6360247
  25. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase: overview, genetic heterogeneity and therapy.
    Birth Defects Orig Artic Ser. 1983;19(3):73-81 PMID: 6418227
  26. Epstein-Barr virus susceptibility of normal human B lymphocyte populations.
    J Exp Med. 1984 Jan 1;159(1):208-20 PMID: 6319530
  27. A new method for the detection of Lesch-Nyhan heterozygotes by peripheral blood T cell culture using T cell growth factor.
    Blood. 1984 Apr;63(4):912-6 PMID: 6608383
  28. Epstein-Barr virus transforms precursor B cells even before immunoglobulin gene rearrangements.
    Nature. 1984 May 24-30;309(5966):369-72 PMID: 6328311
  29. Physiology of B cells in mice with X-linked immunodeficiency (xid). III. Disappearance of xid B cells in double bone marrow chimeras.
    J Exp Med. 1984 Sep 1;160(3):711-23 PMID: 6381637
  30. In vitro regulation of IgA subclass synthesis. II. The source of IgA2 plasma cells.
    J Immunol. 1984 Nov;133(5):2312-6 PMID: 6332844
  31. B cells in patients with X-linked agammaglobulinemia.
    J Immunol. 1985 May;134(5):3070-4 PMID: 3920309
  32. Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency.
    N Engl J Med. 1985 May 2;312(18):1151-9 PMID: 2984567
  33. Relationship between immunoglobulin production and immortalization by Epstein Barr virus.
    J Immunol. 1985 Aug;135(2):959-64 PMID: 2989369
  34. Haploidentical bone marrow transplantation for severe combined immunodeficiency disease using soybean agglutinin-negative, T-depleted marrow cells.
    J Clin Immunol. 1985 Nov;5(6):370-6 PMID: 3910675
  35. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
    J Immunol. 1986 Apr 1;136(7):2398-407 PMID: 2869085
  36. Expression of the gene defect in X-linked agammaglobulinemia.
    N Engl J Med. 1986 Aug 28;315(9):564-7 PMID: 3488506
  37. In vitro regulation of IgA subclass production. III. Selective transformation of IgA1 producing cells by Epstein-Barr virus.
    J Immunol. 1987 Mar 1;138(5):1403-7 PMID: 3027178
  38. Development of B lymphocytes in mice heterozygous for the X-linked immunodeficiency (xid) mutation. xid inhibits development of all splenic and lymph node B cells at a stage subsequent to their initial formation in bone marrow.
    J Exp Med. 1987 Apr 1;165(4):949-58 PMID: 3494095
  39. Immunoglobulin levels of sera of genetically thymusless (nude) mice.
    Eur J Immunol. 1973 Feb;3(2):117-8 PMID: 4715665
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1988-05-00
Pages
3090-4
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC280149
Subset
IM
Grants
PHS HHS · A1-21477 · United States
PHS HHS · A1-25129 · United States
NICHD NIH HHS · HD-00657 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]